Back
Vanguard Short-Term Tax-Exempt Bond ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Sell
35
VTES
Vanguard Short-Term Tax-Exempt Bond ETF
Last Price:
$101.56
Seasonality Move:
1.31%
Sell
33
ZBIO
Zenas BioPharma, Inc.
Last Price:
$36.94
Seasonality Move:
-8.13%
Sell
35
Vanguard Short-Term Tax-Exempt Bond ETF (VTES)
is a Sell
Is Vanguard Short-Term Tax-Exempt Bond ETF a Buy, Sell or Hold?
-
The current Vanguard Short-Term Tax-Exempt Bond ETF [VTES] share price is $101.48. The Score for VTES is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
VTES is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $32.59. The Score for ZBIO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VTES Stock Price Chart
What is Vanguard Short-Term Tax-Exempt Bond ETF's stock price today?
-
The Vanguard Short-Term Tax-Exempt Bond ETF share price today is $101.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTES is experiencing selling pressure, which indicates risk of future bearish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $32.59The current trend is moderately bullish and ZBIO is experiencing selling pressure, which indicates risk of future bearish movement.
VTES Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 14.16 | Buy |
| Relative Strength Index (14 RSI): | 47.71 | Sell |
| Chaikin Money Flow: | -94675 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.42 - 101.56) | Sell |
| Bollinger Bands (100): | (101.39 - 101.89) | Sell |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.39 | Buy |
| Relative Strength Index (14 RSI): | 42.51 | Sell |
| Chaikin Money Flow: | -433025 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.8 - 39.38) | Sell |
| Bollinger Bands (100): | (16.79 - 33.43) | Buy |
VTES Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 101.48 | Buy |
| 20-day SMA: | 101.5 | Sell |
| 50-day SMA: | 101.55 | Sell |
| 200-day SMA: | 101.02 | Buy |
| 8-day EMA: | 101.24 | Buy |
| 20-day EMA: | 92.3 | Buy |
| 50-day EMA: | 62.64 | Buy |
| 200-day EMA: | 21.66 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.44 | Sell |
| 20-day SMA: | 37.66 | Sell |
| 50-day SMA: | 32.27 | Buy |
| 200-day SMA: | 17.45 | Buy |
| 8-day EMA: | 37.61 | Sell |
| 20-day EMA: | 34.32 | Sell |
| 50-day EMA: | 23.15 | Buy |
| 200-day EMA: | 7.97 | Buy |
Vanguard Short-Term Tax-Exempt Bond ETF Earnings Growth & VTES Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
Vanguard Short-Term Tax-Exempt Bond ETF Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||